Join us for a special COVID-19 virtual series hosted by the Geisel School of Medicine and co-sponsored by Dartmouth Alumni Relations and Dartmouth's graduate schools.
Attendees must register for each event separately. Space is limited, so register today!
Future session
Special guest and moderator for all sessions
 |
Susan Dentzer D’77 |
COVID-19 vaccines have been developed, tested, manufactured, and approved in record time – but delivering them to people who need them has proved challenging in the United States. How did we get these vaccines so quickly? What is behind the slow pace of the rollout? What has been learned from these experiences? Panelists will dig into these questions and more, with an eye on the future.
 |
Kendall Hoyt, PhD Assistant Professor of Medicine Geisel School of Medicine |
|
|
Jake Reder, PhD CEO, Celdara Medical Pandemic Security Initiative Director of New Ventures Geisel School of Medicine |
|
|
Tillman Gerngross, PhD Professor of Bioengineering Thayer School of Engineering Co-founder and CEO, Adimab and Adagio Therapeutics |
|
|
Daniel Wrapp GR’21 PhD Candidate in Molecular and Cellular Biology Guarini School of Graduate and Advanced Studies |
